News & Activities

Skilled and Mobile: Survey Evidence of AI Researchers' Immigration Preferenceshttps://arxiv.org/abs/2104.07237?utm_source=chatgpt.comRemco Zwetsloot, Baobao Zhang, Noemi Dreksler, Lauren Kahn, Markus Anderljung, Allan Dafoe, Michael C. HorowitzLast revised 5 May 2021Countries, companies, and universities are increasingly competing over top-tier artificial intelligence (AI) researchers. Where are these researchers likely to immigrate and what affects their immigration decisions? We conducted a survey (n=524) of the immigration preferences and motivations of researchers that had papers accepted at one of two prestigious AI conferences: the Conference on Neural Information Processing Systems (NeurIPS) and the International Conference on Machine Learning (ICML). We find that the U.S. is the most popular destination for AI researchers, followed by the U.K., Canada, Switzerland, and France. A country's professional opportunities stood out as the most common factor that influences immigration decisions of AI researchers, followed by lifestyle and culture, the political climate, and personal relations. The destination country's immigration policies were important to just under half of the researchers surveyed, while around a quarter noted current immigration difficulties to be a deciding factor. Visa and immigration difficulties were perceived to be a particular impediment to conducting AI research in the U.S., the U.K., and Canada. Implications of the findings for the future of AI talent policies and governance are discussed.Subjects:Computers and Society (cs.CY)ACM classes:K.7.4Cite as:arXiv:2104.07237 [cs.CY] (or arXiv:2104.07237v2 [cs.CY] for this version) https://doi.org/10.48550/arXiv.2104.07237Focus to learn moreRelated DOI:https://doi.org/10.1145/3461702.3462617

Directive (EU) 2016/801: Short-term mobility of researchershttps://ind.nl/en/residence-permits/work/directive-eu-2016801-short-term-mobility-of-researchers#what-is-short-term-mobility-You have a residence permit as a researcher in a different EU country under Directive (EU) 2016/801. You are coming for a maximum of 180 days out of a 360-day period to carry out research in the Netherlands. Find out what the requirements are and what the process is.What is short-term mobility?Directive (EU) 2016/801 provides that researchers from outside the European Union (EU), European Economic Area (EEA) or Switzerland can carry out their research in several EU countries. This is called intra-EU-mobility. Researchers choose a first EU Member State where they are going to carry out research. Afterwards the researcher can carry out parts of the research in one or more other EU countries.There are 2 forms of intra-EU mobility for researchers.Short-term mobility: the researcher comes to the Netherlands to carry out research for a maximum of 180 days out of a 360-day period. No residence permit is required for short-term mobility. Your residence permit in the other country is also valid in the Netherlands.Long-term mobility: the researcher will come to carry out research in the Netherlands for more than 180 days. A residence permit is required for long-term mobility. Find out more on the web page Residence permit researcher (Directive (EU) 2016/801).Family members of researchersDo your family members in the other EU country have residence permits to live with you? Then they can come along with you to the Netherlands. Your family members do not need Dutch residence permits either. The residence permit from the other EU country must remain valid during the whole period. You must notify the IND yourself of the arrival of your family members with a notification.Requirementshttps://ind.nl/en/residence-permits/work/directive-eu-2016801-short-term-mobility-of-researchers#requirementsThe following requirements apply to short-term mobility for researchers:You have a valid residence permit for the purpose of research under Directive (EU) 2016/801 in a different EU country, except for Ireland en Denmark.You are coming to the Netherlands for a maximum of 180 days out of a period of 360 days. Your residence permit from the other EU country will remain valid during your stay in the Netherlands.You are going to carry out research at a research institution in the Netherlands. This research institution is recognised by the IND as sponsor. A recognised sponsor is listed in the Public Register Recognised Sponsors.You have a host agreement with the Dutch research institution. The host agreement contains the following information:the title or purpose of the research;a statement that you will try to carry out all of the research;a statement that the research institution will receive you for the purpose of completing the research;the start and end dates of the research, or the estimated duration of the research;information about the research that you are going to carry out in other EU countries, if this information is known;the legal relationship between you and your employer, for example an employment contract; andyour terms and conditions of employment.You will earn sufficient income. Will you not receive a salary from your Dutch employer? Then you must have different income. For example a scholarship, grant or money from a sponsor. Or you must have sufficient money in your bank account for the time you are in the Netherlands.There are no reasons to assume that you want to live in the Netherlands for a purpose other than to carry out research.You are not a danger to the public order or national security. Resident PermitsDo you want to work in the Netherlands or do you want to hire a foreign employee? Then you need a residence permit or a work permit in some cases.Highly skilled migranthttps://ind.nl/en/residence-permits/work/highly-skilled-migrantTo work in the Netherlands as a highly skilled migrant, you need a residence permit. Only an employer recognised by the IND can apply for your permit. Read what the requirements are and how your employer can apply.European Blue Card residence permithttps://ind.nl/en/residence-permits/work/european-blue-card-residence-permitWith a European Blue Card, you can work in the Netherlands as a highly educated migrant. Find out what the requirements are and how your employer can apply for the permit.Residence permit researcher (Directive (EU) 2016/801)https://ind.nl/en/residence-permits/work/residence-permit-researcher-directive-eu-2016801Under Directive (EU) 2016/801 you are allowed to work as a researcher in the Netherlands. Find out what the requirements are and how your employer applies for the permit.

Graduate Women International (GWI)Eligibility: Women worldwide pursuing postgraduate studies who are currently enrolled for a PhD.Dead Line: 15 January 2025Contry: SwitzerlandMore Information: https://www.scientifyresearch.org/grant/international-fellowship-women-phd-worldwide/ The International Fellowship from Graduate Women International (GWI) supports women scholars from around the globe in their pursuit of higher education and research and empower the next generation of female leaders and change-makers. This year, we invite applications from women pursuing postgraduate studies who are currently enrolled for a PhD. GWI fellowships and grants are open free of charge to women PhD candidates who are members of GWI.Several fellowships are available with funding support of up to 6000 GBP.

AboutThe current Expression of Interest is intended for searching post-doctoral candidates with interest in applying for the Marie Skłodowska-Curie GLOBAL Postdoctoral Fellowship 2024 (HORIZON-TMA-MSCA-PF-GF) at AO Research Institute Davos (ARI, Switzerland) as Host Institution for the outgoing phase (12-24 months), followed by a mandatory 12-month return phase to a host institution based in an EU Member state / Associated Country.NOTE: Being Switzerland currently classified as “not associated third country”, it is NOT possible to apply for MSCA European Postdoctoral Fellowships with a Swiss host. It is only possible to apply for GLOBAL Fellowship with the Swiss host in the outgoing phase.Call deadline is 11 September 2024.Potential candidates must comply with the following eligibility criteria of the MSCA Postdoctoral Fellowship callHorizon Europe MSCA - How to apply - European Commission (europa.eu)To be National or long-term resident (5 consecutive years spent in an EU Member state / Associated Country),To be in possession of the PhD at the call deadline,To have a maximum of 8 years of research experience at the call deadline (few exceptions are possible),To comply with the mobility rule: do not have resided or carried out the main activity (work or studies) in the country of the Host Institute during the outgoing phase (Switzerland) for more than 12 months in the 3 years before the call deadline.In case of resubmission, to have not received in the previous application a lower score than 70%.Description of the host organization and research groupThe AO Foundation is a medically guided, not-for-profit organization, a global network of surgeons, and the premier education, innovation, and research organization for the surgical treatment of trauma and musculoskeletal disorders.AO Research Institute Davos (ARI) is the research arm of AO Foundation; its mission is promoting excellence in patient care and outcomes in trauma and musculoskeletal disorders. ARI's scientific activities are multidisciplinary and with a very strong approach to basic and translational research, focused on clinical applications and realized through a cooperation network with many industrial partners. ARI has a vast experience in managing and supervising research projects with a portfolio of international (H2020, Horizon Europe) and national (SNSF) competitive projects. In addition, ARI is at the forefront of high-quality international conferences, such as EORS 2010, TERMIS 2017, ESB 2023, and the next EORS 2025. ARI's commitment in fulfilling the highest standards in research is demonstrated by international standard accreditations. The entire ARI is certified according to ISO 9001:2015. The accreditation includes ARI's preclinical facility, which can perform GLP-like studies. Additionally, the Biomechanical Services and Concept Development are certified as medical device manufacturer according to ISO 13485:2016. Also, ARI's preclinical facility fulfils the highest standard of care for animals (AAALAC accreditation).ARI comprises of 3 Research Programmes:Regenerative Orthopaedics (RO) is a multidisciplinary team focusing on a holistic approach to tissue engineering for repair and regeneration of the musculoskeletal system. RO Program has established research activities in the field of bone, cartilage, and intervertebral disc, with a major focus on regenerative medicine, 3D printing, cell and gene therapy and fracture-related infections.The RO comprises of 5 focus areas: Disc & Cartilage Biology area has tissue-specific bioreactors, namely for intervertebral disc and articular joints, that are instrumental for in vitro testing and for investigating the effect of mechano-regulation on cell behaviour.Bone Biology area aims to study the cellular mechanisms involved in the different phases of bone healing and their interplay for a better understanding and further monitoring of the process.Biomedical Materials area develops responsive materials for orthopaedic regeneration with a strong expertise on biopolymers and nanocomposites. Additive manufacturing technologies are used for both basic understanding of biomaterials and cells interaction, and for translational research in the orthopaedic field.Progenitor Biology & Mechanoregulation area investigates the role of multiple stimuli, such as mechanical stimulation, growth factors and gene therapy in the progression of stem cell differentiation.Infection Biology area performs research into clinically relevant preclinical models of fracture related infection including both in vitro and in vivo models, which are used to investigate novel anti-infective interventions such as implant coatings, novel antimicrobials and provide improved understanding of host-pathogen interactions.Sound Guided Tissue Regeneration activities are articulated around the translation of innovative biofabrication technologies for the repair of musculoskeletal disorders and development of cutting-edge 3D in vitro models for drug screening and personalized medicine. The team use sound wave-based approach and other external fields (e.g. light, magnetic, electric) for contactless cell assembly and stimulation. ARI supported the startup Mimix Biotherapeutics which launched the first acoustic bioprinter in 2021. Biomedical Development (BD) offers extensive know-how, expertise, and experience in the fields of biomechanical testing and computational analyses to advance patient care.Preclinical Service (PCF) offers strong expertise and applies animal models to answer questions from academic researchers, clinicians and industrial partners to improve fracture fixation devices, investigate new (bio)-materials and technologies as well as and surgical procedures. Detailed analysis, both from in vitro and in vivo studies is also provided by the Tissue Morphology facility, which is the institutes' core facility for histology and microscopy.How to apply?Interested candidates should send their CV and a motivation letter to Nunzia Di Luise, Scientific Project Officer (nunzia.diluise@aofoundation.org).More Informationhttps://www.aofoundation.org/what-we-do/research-innovation/about